Compare · 2 funds side by side · dividends reinvested

IDNA and ARKG

IDNAiShares×ARKGARK×

Versus in desk

Story of the two · Growth5Y$10,000 five years agoDividends reinvested · both on one scale$9,440IDNA · best of the two

02 / 04

IDNA and ARKG, Ranked

Today

FundFeeYieldYTD1 year3 yrs · yr5 yrs · yrWorst dropVolatilityAssetsAvg rank

iShares Genomics Immunology and Healthcare ETFSectors · Health care0.47%0.64%+69.3%+78.9%+37.1%−1.1%−10.6%29.9%$354M1.1

ARK Genomic Revolution ETFSectors · Health care0.75%0.00%+71.5%+62.1%+30.4%−7.6%−27.5%45.8%$2.2B1.9

Rank among the two1st → 2ndFee, drop and volatility: lower ranks higherAvg rank: mean of the 8 ranks · 1 is best

End-of-day Nov 4, 2026 · returns include dividends · since: IDNA 2019 · ARKG 2014

Head to Head

Swap sides Versus in desk

Head to Head

iShares Genomics Immunology and Healthcare ETF · $354M$9,440

IDNA

ARKG

ARK Genomic Revolution ETF · $2.2B$6,752

$10,000 five years ago, dividends reinvested · they hold 8.3% in common

IDNAMeasureARKG

+69.3%Year to dateJan 1 → Nov 4+71.5%

+78.9%1 yearTotal return+62.1%

+37.1%3 years · per year$10,000 became $25,773 · $22,153+30.4%

−1.1%5 years · per year$10,000 became $9,440 · $6,752−7.6%

0.47%Expense ratio$47 · $75 a year on $10k · lower is better0.75%

0.64%Trailing 12-mo yield$64 · $0 a year on $10k0.00%

−10.6%Worst dropSmaller is better−27.5%

29.9%VolatilityLower is calmer45.8%

IDNAARKG Winner of the row, in its colourEach row: the bigger of the two fills its side

7–1IDNA wins

End-of-day Nov 4, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns

More Ways to See the Pairs

IDNA vs ARKG: Top 5 Holdings

Today

IDNA

33.3%in top 5

ARKG

in top 535.6%

IDNAStockARKG

13.3%MRNAnot top 5

not top 5TEM9.5%

5.6%TWST7.9%

not top 5TXG7.8%

6.3%GMAB.COnot top 5

not top 5CRSP5.3%

not top 5GH5.1%

4.2%REGNnot top 5

3.8%BAYN.DEnot top 5

Held in common8.3%

End-of-day Nov 4, 2026 · share of each fund

IDNA vs ARKG Returns, Every Period

iSharesIDNA

−1.1%

5 years, per year

ARKGARK

−7.6%

5 years, per year

IDNAARKGFaded: behind in that period

3–1IDNA wins

End-of-day Nov 4, 2026 · dividends in · faded = behind in that period

IDNA vs ARKG

YTD

iSharesIDNA

+69.3%

ARKGARK

+71.5%

+69.3%Year to date+71.5%

−10.6%Worst drop · 1Y−27.5%

29.9%Volatility · 1Y45.8%

0.6%Yield0.0%

$354MAssets$2.2B

3–1IDNA wins

End-of-day Nov 4, 2026 · smaller drop and lower volatility win

Cost, Income and Risk

Fees: IDNA, ARKG

Today

0.47%lowest, IDNA

FundExpense ratioFee$10k

IDNA0.47%$47

ARKG0.75%$75

End-of-day Nov 4, 2026 · fee on $10,000 a year

Yields: IDNA, ARKG

0.64%highest, IDNA

FundTrailing yieldYield$10k

IDNA0.64%$64

ARKG0.00%$0

End-of-day Nov 4, 2026 · trailing 12-month yield

Income After Fees on $10,000

$17most kept, IDNA

IDNA$64 − $47 = $17

ARKG$0 − $75 = −$75

KeptFee

End-of-day Nov 4, 2026 · yield in dollars minus the fee

Overlap: IDNA, ARKG

Today

8.3%most shared, IDNA and ARKG

IDNAARKG

IDNA—8.3%

ARKG8.3%—

End-of-day Nov 4, 2026 · share held in common · outlined: the pair in versus

Return vs Bumpiness: 2 ETFs

+78.9%IDNA, at 29.9% volatility

IDNAWorst drop−10.6%29.9% vol

ARKGWorst drop−27.5%45.8% vol

End-of-day Nov 4, 2026 · up and left is better

Paid More vs Made More

YTD

IDNAARKG

+69.3%Year to date+71.5%

0.6%Yield0.0%

+78.9%Past year+62.1%

0.47%Fee0.75%

3–1IDNA wins

End-of-day Nov 4, 2026

Popular Pairs Near These Two

SCHD vs VIG

YTD

SchwabSCHD

+35.3%

VIGVanguard

+16.4%

+35.3%Year to date+16.4%

2.9%Yield1.4%

$123BAssets$109B

2–0SCHD wins

End-of-day Nov 4, 2026

JEPQ vs JEPI

YTD

J.P. MorganJEPQ

+8.5%

JEPIJ.P. Morgan

+8.8%

+8.5%Year to date+8.8%

12.2%Yield7.8%

$42.1BAssets$46.1B

1–1level

End-of-day Nov 4, 2026

SPYM vs SPY

YTD

SPDRSPYM

+13.4%

SPYSPDR

+13.3%

+13.4%Year to date+13.3%

1.0%Yield1.0%

$182BAssets$805B

1–0SPYM wins

End-of-day Nov 4, 2026